Updated on 13 Nov 2026, 08:13 AM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,886.80 | -0.49 | 4,52,695.85 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 11,450.00 | 1.19 | 3,03,961.52 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,718.95 | -0.92 | 1,79,487.27 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,410.00 | -0.49 | 1,13,912.22 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,205.50 | 1.29 | 1,20,249.09 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-05-04 | Audited Results & Others |
| 2026-02-10 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
Wockhardt is trading at 2056.35 as on Thu Nov 12 2026 10:22:59. This is 1.06% upper as compared to its previous closing price of 2034.70.
The market capitalization of Wockhardt is 33392.12 Cr as on Thu Nov 12 2026 10:22:59.
The 52 wk high for Wockhardt is 2420.00 whereas the 52 wk low is 1086.80
Wockhardt can be analyzed on the following key metrics -
Wockhardt reported a net profit of 213.00 Cr in 2026.
The Mutual Fund Shareholding was 5.99% at the end of 30 Sep 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.